D‐Dimer Enhances Risk‐Targeted Thromboprophylaxis in Ambulatory Patients with Cancer

Primary Thromboprophylaxis in Ambulatory Cancer Patients: Where Do We Stand?

(2020) Frits I. Mulder et al.   Cancers

The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis

(2019) Frits I. Mulder et al.   HAEMATOLOGICA

Dynamic Thromboembolic Risk Modelling to Target Appropriate Preventative Strategies for Patients with Non-Small Cell Lung Cancer

(2019) Marliese Alexander et al.   Cancers

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer

(2019) Alok A. Khorana et al.   NEW ENGLAND JOURNAL OF MEDICINE

The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH

(2019) Tzu‐Fei Wang et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

(2019) Nigel S. Key et al.   JOURNAL OF CLINICAL ONCOLOGY

The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement

(2019) David M. Kent et al.   ANNALS OF INTERNAL MEDICINE

2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

(2019) Dominique Farge et al.   LANCET ONCOLOGY

A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts

(2018) Ingrid Pabinger et al.   Lancet Haematology

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

(2018) Marc Carrier et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study

(2017) Nick van Es et al.   HAEMATOLOGICA

Review of D-dimer testing: Good, Bad, and Ugly

(2017) L.-A. Linkins et al.   International Journal of Laboratory Hematology

From Trial to Target Populations — Calibrating Real-World Data

(2017) Mehdi Najafzadeh et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study

(2017) Nick van Es et al.   HAEMATOLOGICA

d ‐Dimer Levels Over Time and the Risk of Recurrent Venous Thromboembolism: An Update of the Vienna Prediction Model

(2014) Sabine Eichinger et al.   Journal of the American Heart Association

Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer

(2012) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

pROC: an open-source package for R and S+ to analyze and compare ROC curves

(2011) Xavier Robin et al.   BMC BIOINFORMATICS

Prediction of venous thromboembolism in cancer patients

(2010) C. Ay et al.   BLOOD

Epidemiology of cancer-related venous thromboembolism

(2009) Ted Wun et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

(2009) Giancarlo Agnelli et al.   LANCET ONCOLOGY

Development and validation of a predictive model for chemotherapy-associated thrombosis

(2008) A. A. Khorana et al.   BLOOD